Carolyn Porter
Nessuna posizione attualmente
Profilo
Carolyn Porter worked as a Director at Oxstem Ltd.
and Xerion Healthcare Ltd.
Precedenti posizioni note di Carolyn Porter
| Società | Posizione | Fine |
|---|---|---|
Xerion Healthcare Ltd.
 Xerion Healthcare Ltd. BiotechnologyHealth Technology Xerion Healthcare Ltd. develops and commercializes nanoparticle treatment to cure head, and neck and lung cancer. It injects Nanoparticles into tumours and generates free radicals by splitting water rather than interacting with oxygen. The firm’s nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material. The company was founded by Gareth Wakefield and Helen Townley in 2015 and is headquartered in Thame, the United Kingdom. | Direttore/Membro del Consiglio | 09/10/2017 |
Oxstem Ltd.
 Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Oxstem Ltd.
Oxstem Ltd. BiotechnologyHealth Technology Oxstem Ltd. develops cell programming therapies. The company is headquartered in Oxford, the United Kingdom. | Health Technology |
Xerion Healthcare Ltd.
Xerion Healthcare Ltd. BiotechnologyHealth Technology Xerion Healthcare Ltd. develops and commercializes nanoparticle treatment to cure head, and neck and lung cancer. It injects Nanoparticles into tumours and generates free radicals by splitting water rather than interacting with oxygen. The firm’s nanoparticles are based on titanium dioxide, a common, non-toxic, semiconductor material. The company was founded by Gareth Wakefield and Helen Townley in 2015 and is headquartered in Thame, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Carolyn Porter
